(4) In contrast with the risk of all-grade rash, alopecia, and palmoplantar keratoderma, the risk of high-grade rash, alopecia, palmoplantar keratoderma, and photosensitivity reaction were similar between the BRAF and MEK inhibitor therapy and BRAF inhibitor monotherapy. The gene discussed is MAP2K7; the disease is alopecia.